Utilities·Renewable Electricity·$7.0B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.04 | N/A | -200.00% |
management commentary, guidance changes, and full analysis available with Pro.
| -200.00% |
Tone: Defensive
Management acknowledged the difficulties faced in the quarter. They emphasized the need for strategic adjustments moving forward.
Management expressed concerns over current market conditions.
They highlighted ongoing challenges in operational efficiency.
Ormat Technologies reported a loss per share of $0.04, which was below expectations, contributing to a slight decline in stock price by 0.71%. The management's cautious tone suggests they are facing challenges that may impact future performance. Investors may need to consider these factors as they evaluate the company's outlook.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
ALNYLAM PHARMACEUTIC
May 6, 2013